Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2004

View Archived Issues

Antitumor effects of CpG-7909 in several types of human cancer

Synthetic Australian snake venom derivative effective for wound healing

Restoration of CFTR function with SV40 gene therapy

Antitumor effects and safety of rhLF in advanced cancer patients

Novel potent and selective 5-HT2C agonists for the treatment of obesity discovered at Wyeth

Study results on GLP-1 analogue CJC-1131 presented during ADA

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

An EGF vaccine reported to improve survival in advanced lung cancer

Positive preliminary phase III results for Sativex in neuropathic pain

Crucell enters PER.C6 licensing agreement with Chiron

FDA accepts IND for stem cell mobilizing drug CTCE-0214

Sosei's phase I trial of SOU-001 cleared to begin in U.K.

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

Symadex enters phase I in patients with advanced solid tumors

SVT-40776 progresses into phase II for urinary incontinence

Daily Infergen plus ribavirin evaluated for HCV in new DIRECT trial

Ovation acquires Buronil from Lundbeck

IR-103 enters first clinical study for HIV

First phase IIa patients receive BrachySil for liver cancer

Two series of gamma-secretase inhibitors identified at Merck

AstraZeneca presents novel PTP-1B inhibitors

Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

New antilipolytic agents targeting hRUP38 receptors

T-614 reported safe and effective in patients with active rheumatoid arthritis

Novel chemokine CCR1 antagonists and their use covered by Pfizer patent

New monoamine reuptake inhibitors developed at NeuroSearch

Preliminary data on the efficacy of epratuzumab in SLE

Clinical response found with eculizumab in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...